We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis.
- Authors
You, Hong-Juan; Ma, Li-Hong; Wang, Xing; Wang, Yu-Xin; Zhang, Huan-Yang; Bao, En-Si; Zhong, Yu-Jie; Liu, Xiang-Ye; Kong, De-Long; Zheng, Kui-Yang; Kong, Fan-Yun; Tang, Ren-Xian
- Abstract
Purpose: As a vital component of the hepatitis B virus (HBV) nucleocapsid, HBV core protein (HBC) contributes to hepatocarcinogenesis. Here, we aimed to assess the effects of RANGAP1 and KDM2A on tumorigenesis induced by HBC. Methods: Co-immunoprecipitation (Co-IP) combined with mass spectrometry were utilized to identify the proteins with the capacity to interact with HBC. The gene and protein levels of RANGAP1 and KDM2A in hepatocellular carcinoma (HCC) and HBV-positive HCC tissues were evaluated using different cohorts. The roles of RANGAP1 and KDM2A in HCC cells mediated by HBC were investigated in vitro and in vivo. Co-IP and western blot were used to estimate the interaction of HBC with RANGAP1 and KDM2A and assess RANGAP1 stabilization regulated by HBC. Results: We discovered that HBC could interact with RANGAP1 and KDM2A, the levels of which were markedly elevated in HCC tissues. Relying on RANGAP1 and KDM2A, HBC facilitated HCC cell growth and migration. The increased stabilization of RANGAP1 mediated by HBC was relevant to the disruption of the interaction between RANGAP1 and an E3 ligase SYVN1. RANGAP1 interacted with KDM2A, and it further promoted KDM2A stabilization by disturbing the interaction between KDM2A and SYVN1. HBC enhanced the interaction of KDM2A with RANGAP1 and upregulated the expression of KDM2A via RANGAP1 in HCC cells. Conclusions: These findings demonstrate a novel mechanism by which HBC facilitates hepatocarcinogenesis. RANGAP1 and KDM2A could act as potential molecular targets for treating HBV-associated malignancy.
- Subjects
HUDSON'S Bay Co.; VIRAL proteins; HEPATITIS B virus; UBIQUITIN ligases; HEPATOCELLULAR carcinoma; DRUG target; CELL growth
- Publication
Cellular Oncology (2211-3428), 2024, Vol 47, Issue 2, p639
- ISSN
2211-3428
- Publication type
Article
- DOI
10.1007/s13402-023-00889-4